Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Efficacy of Tenofovir Disoproxil Fumarate in Preventing Vertical Transmission of Hepatitis B in Mothers with Chronic Hepatitis B: An Evidence-Based Case Report

ACTA MEDICA INDONESIANA · Vol. 56 No. 3 (2024)

ISSN
2338-2732, 0125-9326
Terbit
2024-10-25
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Background: Hepatitis B virus infection is the most common cause of chronic hepatitis. Vertical transmission is the main transmission route of this virus. Current prevention involves giving newborns immune prophylaxis within 12 hours of birth. However, there is still a failure of immunoprophylaxis, especially in cases of mothers who have a high viral load or are HBeAg positive. Tenofovir disoproxil fumarate (TDF) is the first-line treatment for chronic hepatitis B and is known to reduce perinatal HBV transmission. This study aims to determine the efficacy of TDF in preventing vertical transmission in pregnant women with chronic hepatitis B. Methods: A literature search was performed on the online databases of PubMed/MEDLINE, Embase, Scopus, Cochrane, and ScienceDirect. The inclusion criteria used were pregnant women with chronic hepatitis B and using TDF antiviral as a transmission prevention therapy with the study design used in the form of a meta-analysis, systematic review, randomized or nonrandomized controlled trial. The outcome of interest was the vertical transmission rate of hepatitis B. Results: There are two studies used with a meta-analysis study design and a nonrandomized controlled trial with a good critical review result of Validity, Importance, and Applicability. TDF significantly prevented vertical transmission of hepatitis B compared to placebo. In addition, TDF was not associated with the incidence of maternal and fetal complications. Conclusion: TDF has high effectiveness in preventing vertical transmission of hepatitis B and is safe to give to pregnant women.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 176 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Juferdy KurniawanAfiliasi tidak diketahui8
Robert SintoAfiliasi tidak diketahui6
Rino Alvani GaniAfiliasi tidak diketahui5
Ikhwan RinaldiAfiliasi tidak diketahui5
Khie Chen LieAfiliasi tidak diketahui4
Leonard NainggolanAfiliasi tidak diketahui4
Cleopas Martin RumendeAfiliasi tidak diketahui4
Andri SanityosoAfiliasi tidak diketahui3
Cosmas Rinaldi A LesmanaAfiliasi tidak diketahui3
Chyntia Olivia Maurine JasirwanAfiliasi tidak diketahui3
Kemal Fariz KalistaAfiliasi tidak diketahui3
Andri Sanityoso SulaimanAfiliasi tidak diketahui3
Sharifah ShakinahAfiliasi tidak diketahui3
Gita ApriliciaAfiliasi tidak diketahui3
Hamzah ShatriAfiliasi tidak diketahui3
Rino A GaniAfiliasi tidak diketahui2
Mulya Rahma KaryantiAfiliasi tidak diketahui2
Rahajeng N TunjungputriAfiliasi tidak diketahui2
Randy AdiwinataAfiliasi tidak diketahui2
Ignatius Bima PrasetyaAfiliasi tidak diketahui2
Murdani AbdullahAfiliasi tidak diketahui2
Adityo SusiloAfiliasi tidak diketahui2
Sally Aman NasutionAfiliasi tidak diketahui2
Maulana SuryaminAfiliasi tidak diketahui1
C. Rinaldi A LesmanaAfiliasi tidak diketahui1
Indra WijayaAfiliasi tidak diketahui1
Felix F WidjajaAfiliasi tidak diketahui1
Paramita KhairanAfiliasi tidak diketahui1
Telly KameliaAfiliasi tidak diketahui1
Marcellus SimadibrataAfiliasi tidak diketahui1
Lutfie LutfieAfiliasi tidak diketahui1
Wismandari WisnuAfiliasi tidak diketahui1
Guntur DarmawanAfiliasi tidak diketahui1
Laniyati HamijoyoAfiliasi tidak diketahui1
Esthika DewiastyAfiliasi tidak diketahui1
Candra WigunaAfiliasi tidak diketahui1
Imelda Maria LohoAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc) 
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Efficacy of Tenofovir Disoproxil Fumarate in Preventing Vertical Transmission of Hepatitis B in Mothers with Chronic Hepatitis B: An Evidence-Based Case Report</dc:title>
	<dc:creator>Felim, Ris Raihan</dc:creator>
	<dc:creator>Hasan, Irsan</dc:creator>
	<dc:creator>Nelwan, Erni Juwita</dc:creator>
	<dc:subject xml:lang="en-US">Hepatitis B</dc:subject>
	<dc:subject xml:lang="en-US">Vertical transmission</dc:subject>
	<dc:subject xml:lang="en-US">Tenofovir Disoproxil Fumarate</dc:subject>
	<dc:description xml:lang="en-US">Background: Hepatitis B virus infection is the most common cause of chronic hepatitis. Vertical transmission is the main transmission route of this virus. Current prevention involves giving newborns immune prophylaxis within 12 hours of birth. However, there is still a failure of immunoprophylaxis, especially in cases of mothers who have a high viral load or are HBeAg positive. Tenofovir disoproxil fumarate (TDF) is the first-line treatment for chronic hepatitis B and is known to reduce perinatal HBV transmission. This study aims to determine the efficacy of TDF in preventing vertical transmission in pregnant women with chronic hepatitis B. Methods: A literature search was performed on the online databases of PubMed/MEDLINE, Embase, Scopus, Cochrane, and ScienceDirect. The inclusion criteria used were pregnant women with chronic hepatitis B and using TDF antiviral as a transmission prevention therapy with the study design used in the form of a meta-analysis, systematic review, randomized or nonrandomized controlled trial. The outcome of interest was the vertical transmission rate of hepatitis B. Results: There are two studies used with a meta-analysis study design and a nonrandomized controlled trial with a good critical review result of Validity, Importance, and Applicability. TDF significantly prevented vertical transmission of hepatitis B compared to placebo. In addition, TDF was not associated with the incidence of maternal and fetal complications. Conclusion: TDF has high effectiveness in preventing vertical transmission of hepatitis B and is safe to give to pregnant women.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2024-10-25</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/2585</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 56 No. 3 (2024): Acta Medica Indonesiana; 411</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/2585/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2024 Ris Raihan Felim, Muhammad Kevin Ardian, Erni J Nelwan, Irsan Hasan</dc:rights>
</oai_dc:dc>